Back
Solid Biosciences 10K Form
Buy
59
SLDB
Solid Biosciences
Last Price:
3.74
Seasonality Move:
-3.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-06 | 10Q | SLDB/Solid Biosciences Quarterly |
| 2020-05-07 | 10Q | SLDB/Solid Biosciences Quarterly |
| 2020-03-13 | 10K | SLDB/Solid Biosciences Annual |
| 2020-03-12 | 10K | SLDB/Solid Biosciences Annual |
| 2019-11-12 | 10Q | SLDB/Solid Biosciences Quarterly |
| 2019-08-14 | 10Q | SLDB/Solid Biosciences Quarterly |
Receive SLDB News And Ratings
See the #1 stock for the next 7 days that we like better than SLDB
SLDB Financial Statistics
Sales & Book Value
| Annual Sales: | $8.09M |
|---|---|
| Cash Flow: | $-18.28M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.20 |
| Price / Book: | 0.52 |
Profitability
| EPS (TTM): | -19.30680 |
|---|---|
| Net Income (TTM): | $-90.83M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Solid Biosciences Earnings Forecast
Key Solid Biosciences Financial Ratios
- The Research & Development expenses have been 969.34% of Revenue.
- The Net Earning history of SLDB is -1,062.79% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 3 years.
Solid Biosciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | SLDB |
| CUSIP: | 83422E |
| Website: | solidbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SLDB Technical Analysis vs Fundamental Analysis
Buy
59
Solid Biosciences (SLDB)
is a Buy
Is Solid Biosciences a Buy or a Sell?
-
Solid Biosciences stock is rated a Buy
The current Solid Biosciences [SLDB] share price is $3.73. The Score for SLDB is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.